These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 26436854
21. NAD+ attenuates experimental autoimmune encephalomyelitis through induction of CD11b+ gr-1+ myeloid-derived suppressor cells. Wang JL, Li B, Tan GJ, Gai XL, Xing JN, Wang JQ, Quan MY, Zhang N, Guo L. Biosci Rep; 2020 Apr 30; 40(4):. PubMed ID: 32301489 [Abstract] [Full Text] [Related]
23. Mesenchymal Stem Cells Attenuated Blood-Brain Barrier Disruption via Downregulation of Aquaporin-4 Expression in EAE Mice. Liu Y, Ma Y, Du B, Wang Y, Yang GY, Bi X. Mol Neurobiol; 2020 Sep 30; 57(9):3891-3901. PubMed ID: 32613467 [Abstract] [Full Text] [Related]
26. Transcript analysis of laser capture microdissected white matter astrocytes and higher phenol sulfotransferase 1A1 expression during autoimmune neuroinflammation. Guillot F, Garcia A, Salou M, Brouard S, Laplaud DA, Nicot AB. J Neuroinflammation; 2015 Jul 04; 12():130. PubMed ID: 26141738 [Abstract] [Full Text] [Related]
27. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses. Feng M, Shu Y, Yang Y, Zheng X, Li R, Wang Y, Dai Y, Qiu W, Lu Z, Hu X. Neurochem Int; 2014 Jan 04; 64():64-72. PubMed ID: 24274996 [Abstract] [Full Text] [Related]
28. Mice Heterozygous for the Sodium Channel Scn8a (Nav1.6) Have Reduced Inflammatory Responses During EAE and Following LPS Challenge. Alrashdi B, Dawod B, Tacke S, Kuerten S, Côté PD, Marshall JS. Front Immunol; 2021 Jan 04; 12():533423. PubMed ID: 33815353 [Abstract] [Full Text] [Related]
29. Suppression of neuro inflammation in experimental autoimmune encephalomyelitis by glia maturation factor antibody. Zaheer S, Wu Y, Sahu SK, Zaheer A. Brain Res; 2011 Feb 10; 1373():230-9. PubMed ID: 21146509 [Abstract] [Full Text] [Related]
30. Carboxypeptidase N-deficient mice present with polymorphic disease phenotypes on induction of experimental autoimmune encephalomyelitis. Hu X, Wetsel RA, Ramos TN, Mueller-Ortiz SL, Schoeb TR, Barnum SR. Immunobiology; 2014 Feb 10; 219(2):104-8. PubMed ID: 24028840 [Abstract] [Full Text] [Related]
31. Immunomodulatory effects and improved prognosis of experimental autoimmune encephalomyelitis after O-tetradecanoyl-genistein treatment. Castro SB, Junior CO, Alves CC, Dias AT, Alves LL, Mazzoccoli L, Mesquita FP, Figueiredo NS, Juliano MA, Castañon MC, Gameiro J, Almeida MV, Teixeira HC, Ferreira AP. Int Immunopharmacol; 2012 Feb 10; 12(2):465-70. PubMed ID: 22245971 [Abstract] [Full Text] [Related]
32. Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption. Souza PS, Gonçalves ED, Pedroso GS, Farias HR, Junqueira SC, Marcon R, Tuon T, Cola M, Silveira PCL, Santos AR, Calixto JB, Souza CT, de Pinho RA, Dutra RC. Mol Neurobiol; 2017 Aug 10; 54(6):4723-4737. PubMed ID: 27447807 [Abstract] [Full Text] [Related]
33. Severe disease, unaltered leukocyte migration, and reduced IFN-gamma production in CXCR3-/- mice with experimental autoimmune encephalomyelitis. Liu L, Huang D, Matsui M, He TT, Hu T, Demartino J, Lu B, Gerard C, Ransohoff RM. J Immunol; 2006 Apr 01; 176(7):4399-409. PubMed ID: 16547278 [Abstract] [Full Text] [Related]
34. LFA-1 Controls Th1 and Th17 Motility Behavior in the Inflamed Central Nervous System. Dusi S, Angiari S, Pietronigro EC, Lopez N, Angelini G, Zenaro E, Della Bianca V, Tosadori G, Paris F, Amoruso A, Carlucci T, Constantin G, Rossi B. Front Immunol; 2019 Apr 01; 10():2436. PubMed ID: 31681316 [Abstract] [Full Text] [Related]
35. Alendronate alleviates the symptoms of experimental autoimmune encephalomyelitis. Jung K, Kim J, Ahn G, Matsuda H, Akane T, Ahn M, Shin T. Int Immunopharmacol; 2020 Jul 01; 84():106534. PubMed ID: 32361191 [Abstract] [Full Text] [Related]
36. Anti-Inflammatory Effect of KW-2449 on Autoimmune Encephalomyelitis: An Experimental Study on Mice. Ahmadabad HN, Abbaspour A, Panahi Y, Tahmasebi S, Hossein-Khannazer N, Afraei S, Miladi H, Goudarzvand M, Kamali AN, Bagheri Y, Yazdani R, Di Fiore MM, Azizi G. Endocr Metab Immune Disord Drug Targets; 2021 Jul 01; 21(9):1590-1597. PubMed ID: 33155932 [Abstract] [Full Text] [Related]
37. Nicotinamide adenine dinucleotide treatment alleviates the symptoms of experimental autoimmune encephalomyelitis by activating autophagy and inhibiting the NLRP3 inflammasome. Wang X, Li B, Liu L, Zhang L, Ma T, Guo L. Int Immunopharmacol; 2021 Jan 01; 90():107092. PubMed ID: 33290962 [Abstract] [Full Text] [Related]
38. Consistent induction of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice for the longitudinal study of pathology and repair. Hasselmann JPC, Karim H, Khalaj AJ, Ghosh S, Tiwari-Woodruff SK. J Neurosci Methods; 2017 Jun 01; 284():71-84. PubMed ID: 28396177 [Abstract] [Full Text] [Related]
39. Gelatinase B/matrix metalloproteinase-9 is a phase-specific effector molecule, independent from Fas, in experimental autoimmune encephalomyelitis. Ugarte-Berzal E, Berghmans N, Boon L, Martens E, Vandooren J, Cauwe B, Thijs G, Proost P, Van Damme J, Opdenakker G. PLoS One; 2018 Jun 01; 13(10):e0197944. PubMed ID: 30273366 [Abstract] [Full Text] [Related]
40. CXCL12 expression within the CNS contributes to the resistance against experimental autoimmune encephalomyelitis in Albino Oxford rats. Miljković D, Stanojević Z, Momcilović M, Odoardi F, Flügel A, Mostarica-Stojković M. Immunobiology; 2011 Sep 01; 216(9):979-87. PubMed ID: 21601937 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]